[{"Assets_0_Q1_USD":209454000.0,"CommonStockSharesOutstanding_0_Q1_shares":30129240.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-21192000.0,"NetIncomeLoss_1_Q1_USD":-27156000.0,"StockholdersEquity_0_Q1_USD":178671000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170509"}]